Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.4%

2 terminated out of 59 trials

Success Rate

93.9%

+7.4% vs benchmark

Late-Stage Pipeline

27%

16 trials in Phase 3/4

Results Transparency

26%

8 of 31 completed with results

Key Signals

8 with results94% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (16)
Early P 1 (3)
P 1 (5)
P 2 (3)
P 3 (5)
P 4 (11)

Trial Status

Completed31
Unknown12
Withdrawn5
Not Yet Recruiting5
Recruiting4
Terminated2

Trial Success Rate

93.9%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (59)

Showing 20 of 20 trials
NCT07149428Not Yet Recruiting

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT02038166RecruitingPrimary

Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis

NCT06901297Phase 3RecruitingPrimary

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

NCT07383493Not ApplicableNot Yet Recruiting

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

NCT07257224Not Yet Recruiting

Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu Symptoms, Colds, Allergic Rhinitis and Rhinosinusitis in Infants and Toddlers

NCT06580210Recruiting

Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction

NCT05494346Not ApplicableRecruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT06866145Phase 4CompletedPrimary

Dexmedetomidine Infusion in Either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery

NCT07151313Not ApplicableNot Yet Recruiting

Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:

NCT04249427Phase 4Completed

Erenumab for Idiosyncratic Facial Pain

NCT05865613Not ApplicableCompleted

Effect of Electromagnetic Therapy on Patients With Chronic Rhinosinusitis.

NCT01350466CompletedPrimary

Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome

NCT06343493Not ApplicableCompletedPrimary

Effect of Hot Saline Irrigation on the Operative Field During Endoscopic Sinus Surgery

NCT05999955Not ApplicableCompletedPrimary

Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

NCT06149949Unknown

the Prevalence of Chronic Rhinosinusitis Associated With Inflammatory Bowel Disease and Association With Biomarkers of Epithelial Barrier Damage

NCT06105346Not Yet Recruiting

Prevalence of ENT Diseseas

NCT05442606Not ApplicableCompletedPrimary

Physiotherapy Protocol in Treating Chronic Rhinosinusitis

NCT05861817Not ApplicableCompletedPrimary

Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis.

NCT05836935Not ApplicableUnknownPrimary

Role of Imaging in Complications of Sinusitis

NCT03229551Phase 2Completed

Xylitol for Chronic Sinusitis

Scroll to load more

Research Network

Activity Timeline